Global studies
Countries30+
Qualified sites260+
ModelCentralised

A global model built on consistency.

The geographical expansion of a study must not result in a loss of scientific control. Methodological consistency is what makes data comparable, endpoints defensible and the regulatory pathway sustainable.
WIDEN ensures that imaging maintains integrity and consistency, regardless of the geographical complexity of the trial.

Governance

Centralised governance for multicentre clinical trials.

Contemporary clinical trials are increasingly international, multicentre and technologically diverse. Managing imaging in this context requires a methodological infrastructure capable of ensuring consistency, control and traceability across sites spread across multiple countries.

WIDEN supports multicentre studies through centralised management of imaging workflows, ensuring that all data collected — regardless of the centre of origin — meets consistent scientific and regulatory standards.

Our operating model transforms geographical complexity into methodological control.

Standardisation

International standardisation of workflows.

Operating on a global scale does not simply mean coordinating multiple sites, but harmonising every layer of the imaging process so endpoints stay comparable.

Acquisition protocols

Harmonised acquisition protocols define how every scan is performed, so imaging is comparable from the first study onward.

Protocol harmonisation

Technical parameters

Standardised technical parameters are fixed across scanners and vendors to remove avoidable inter-centre variability.

Instrumentation

Quality control processes

Centralised quality control checks each dataset against predefined criteria before it can affect the analysis.

Quality assurance

Review criteria

Shared review criteria and reviewer calibration keep reads consistent and defensible across every site.

Central review

Archiving & traceability

Uniform archiving and traceability systems keep every image and decision auditable across the trial lifecycle.

Regulatory archiving

Continuous monitoring

Structured site qualification and continuous monitoring maintain constant scientific oversight from start to close-out.

Site qualification

Each workflow is designed to ensure cross-country comparability, minimising inter-centre variability that could compromise the robustness of the endpoints.

Operational presence

International operational presence.

We operate within different regulatory frameworks, ensuring methodological consistency and local compliance wherever a study runs.

30+
Countries covered

Uniform, standardised workflows across more than 30 countries — operating within different regulatory frameworks while maintaining methodological consistency and local compliance.

Uniform workflows Local compliance
260+
Qualified sites

Each centre is validated through technical harmonisation and performance verification processes, with a particular focus on quantitative and multicentre studies.

Technical harmonisation Performance verified
Analysis-ready data

The real challenge is not merely to collect images, but to ensure datasets are consistent, verified, traceable and ready for submission.

In international studies, datasets must be consistent across sites, verified against predefined criteria, fully traceable and ready for statistical analysis and regulatory inspection. WIDEN implements centralised quality control systems that identify technical deviations before they impact the primary analysis. The result is a controlled, non-reactive imaging workflow.

Collaborations

International scientific collaborations.

Our role is that of an integrated scientific partner in the methodological design of the study — not simply a vendor at its edges.

International CROs

We integrate with global contract research organisations, plugging imaging governance into existing trial operations.

Operational integration

Biotech sponsors

We support emerging biotech sponsors with the methodological rigour their imaging endpoints require from first-in-human onward.

Endpoint design

Pharmaceutical companies

We partner with pharmaceutical companies running large, multi-country programmes that demand consistent, inspection-ready imaging.

Multi-country programmes

Specialised clinical networks

We work alongside specialised clinical networks, harmonising imaging across their sites within a single traceable platform.

Network harmonisation

Groups whose trials run on WIDEN

Supporting complex international clinical trials.

Find out how we can keep imaging consistent, traceable and inspection-ready across every country your study touches. The scientists who built WIDEN will help you design endpoints, qualify sites and govern the workflow end to end.

Office
Via Agostino da Montefeltro 2
10134 Torino, Italy